The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer

Anaplastic thyroid cancer represents 1%–2% of thyroid cancers. For its aggressiveness, it is considered a systemic disease at the time of diagnosis. Surgery remains the cornerstone of therapy in resectable tumor. Traditional chemotherapy has little effect on metastatic disease. A multimodality appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Denaro, Nerina, Nigro, Cristiana Lo, Russi, Elvio G, Merlano, Marco C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787923/
https://www.ncbi.nlm.nih.gov/pubmed/24092989
http://dx.doi.org/10.2147/OTT.S46545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787923/
https://www.ncbi.nlm.nih.gov/pubmed/24092989
http://dx.doi.org/10.2147/OTT.S46545

Ejemplares similares